Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by wildbird1on May 16, 2018 12:12pm
195 Views
Post# 28039808

''We are fully focused on executing''

''We are fully focused on executing''
Today with the high cost of medication and healthcare, nobody  is willing to buy a test (no matter how good it is) unless they can reclaim part of the cost from there insurance company or on there income tax return, and for the patient to be able to reclaim part of the cost... Genenews money collecting process has to be perfectly synchronize at all level.

Peoples have no idea how complex it is to synchronize this money collecting process when it does involve 5 levels...
Level no:1 = The patient...
          no:2 = The doctor office...
          no:3 = The insurance company...
          no:4 = The healthcare system...
          no:5 = The government...

Unless these 5 levels are perfectly synchronize nobody(patients & insurance company) will be willing to buy the tests (that could explain the low number of tests sold so far).

It may not be an easy task to synchronize this process...but once it is done it will be very very lucrative for Genenews.
A big part of the new money will be used to implement and accelerate the billing process.

Better be ready ...when the synchronization of the billing process is done BIG $ number will start to appear on this board.


Bullboard Posts